Kristine Ashcraft, BS, MBA, is Chief Operating Officer of Genelex, a recognized leader in pharmacogenetic testing and personalized medication management. Kristine joined Genelex in 2000 as Director of Sales and Marketing. A molecular biologist by training, she has more than 15 years of management experience, including more than a decade at Genelex bringing genetic technologies to market. She is responsible for operations, sales strategy, and business development at the company. She is on a mission to improve patient care and bend the healthcare cost curve.

Mark Bartlett is the co-founder and director of Geneix. He has an MSc in Pharmacogenetics and Stratified Medicines from University College London and is passionate about using data to ensure that patients receive the right drug treatments. With a background working for the National Health Service in the UK and published research into physician’s opinions of pharmacogenetics Mark is driven by understanding how complex technologies can be communicated to prescribers to drive better outcomes.